Sonoma Pharmaceuticals (SNOA) Research & Development (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Research & Development of $545000.0 for Q1 2026, up 32.6% year-over-year from $411000.0 in Q1 2025, and down 2.15% quarter-over-quarter from $557000.0 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Research & Development (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Research & Development history runs 17 years deep, the most recent figure standing at $545000.0 for Q1 2026.
- In Q1 2026, Research & Development rose 32.6% year-over-year to $545000.0; the TTM figure through Mar 2026 stood at $2.3 million (up 25.19% YoY), while the FY2026 annual figure was $2.3 million, up 25.19% from the prior year.
- Research & Development for Q1 2026 stood at $545000.0, down from $557000.0 in the prior quarter.
- The five-year high for Research & Development was $601000.0 in Q4 2023, with the low at $4000.0 in Q1 2022.
- The 5-year median for Research & Development is $448500.0 (2024), against an average of $410437.5.
- The sharpest annual moves came in 2022 and 2023: Research & Development tumbled 96.92% in 2022, then soared 4925.0% in 2023.
- Sonoma Pharmaceuticals' Research & Development stood at $200000.0 in 2022, then soared by 200.5% to $601000.0 in 2023, then decreased by 28.95% to $427000.0 in 2024, then surged by 30.44% to $557000.0 in 2025, then declined by 2.15% to $545000.0 in 2026.
- Business Quant data shows SNOA's Research & Development at $545000.0 in Q1 2026, $557000.0 in Q4 2025, and $575000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.12 Mn | -222,819.83 | 2.58 Mn | 597,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 597,000.00 |
| Mar 31, 2026 | 545,000.00 |
| Dec 31, 2025 | 557,000.00 |
| Sep 30, 2025 | 575,000.00 |
| Jun 30, 2025 | 594,000.00 |
| Mar 31, 2025 | 411,000.00 |
| Dec 31, 2024 | 427,000.00 |
| Sep 30, 2024 | 506,000.00 |
| Jun 30, 2024 | 470,000.00 |
| Mar 31, 2024 | 409,000.00 |
| Dec 31, 2023 | 601,000.00 |
| Sep 30, 2023 | 536,000.00 |
| Jun 30, 2023 | 325,000.00 |
| Mar 31, 2023 | 201,000.00 |
| Sep 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 206,000.00 |
| Mar 31, 2022 | 4,000.00 |
| Dec 31, 2021 | 26,000.00 |
| Sep 30, 2021 | 10,000.00 |
| Jun 30, 2021 | 84,000.00 |